parecoxib has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kan, HP; Tan, JH; Zhang, GW; Zhou, L | 1 |
| Chen, Z; Li, L; Li, S; Yang, Y; Zhang, L | 1 |
2 other study(ies) available for parecoxib and Disease Exacerbation
| Article | Year |
|---|---|
Parecoxib Improves the Outcomes of Acute Mild and Moderate Pancreatitis: A 3-Year Matched Cohort Study Based on a Prospective Database.
Topics: Acute Disease; Adult; Bacterial Infections; Cohort Studies; Cyclooxygenase 2 Inhibitors; Databases, Factual; Disease Progression; Female; Fever; Humans; Isoxazoles; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatitis; Protective Agents; Severity of Illness Index | 2019 |
COX‑2 inhibition in the endothelium induces glucose metabolism normalization and impairs tumor progression.
Topics: Animals; Antineoplastic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Progression; Endothelial Cells; Female; Glucose; Glycolysis; Isoxazoles; Mice, Inbred C57BL; Neoplasms; Ovarian Neoplasms; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2018 |